Cargando…
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
Efficacy is the main objective of antiretroviral treatment and adherence is one of the cornerstones to achieve it. For this reason, treatment simplification is of key importance with regard to antiretroviral regimens. Rezolsta® (darunavir/cobicistat) is the first fixed-dose combination containing a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098528/ https://www.ncbi.nlm.nih.gov/pubmed/27843352 http://dx.doi.org/10.2147/HIV.S56158 |